← Leaderboards
Kenneth J Piller
University Of North Carolina Charlotte
$5,419,395
Attributed
$5,695,395
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $685.4K · FY2005–22$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$5,695,395 · 9
By mechanism
R44$2,219,392 · 2
R01$1,358,160 · 2
R43$1,039,494 · 3
R42$877,379 · 1
R41$200,970 · 1
Top collaborators
- Kenneth L Bost2 shared
Others in their field
Top investigators on “Soybeans”
- Gary E. Fraser · Loma Linda University$14,390,970
- Douglas R Cook · University Of California-Davis$5,900,384
- Robert B Goldberg · University Of California-Los Angeles$5,528,366
- John J Harada · University Of California-Davis$5,528,366
- Judith Pollock Klinman · University Of California Berkeley$5,257,534
- Jay J Thelen · University Of Missouri-Columbia$4,834,831
Research focus
SoybeansTechnologyProteinsTransgenic OrganismsSeedsAntigensOralImmune ResponseDiagnosisAnimal ModelSmall Business Innovation Research GrantProductionCostCellsT-LymphocyteResponseProtein ExpressionChimeric ProteinsAutoimmune ResponsesPublic Health RelevancePathogenFutureAmino AcidsDose
Grant awards (17)
Oral autoantigen therapy for the treatment of Multiple Sclerosis$294,973
R43 · FY2022 · AI · contact PI
Oral autoantigen therapy for the treatment of Multiple Sclerosis$288,580
R43 · FY2021 · AI · contact PI
Platform for practical delivery of oral autoantigens as co-therapies for neurological disease$495,665
R44 · FY2017 · NS · contact PI
Platform for practical delivery of oral autoantigens as co-therapies for neurological disease$548,420
R44 · FY2016 · NS · contact PI
Improved diagnostic and monitoring assays for thyroid cancer$393,458
R44 · FY2015 · CA · contact PI
Platform for practical delivery of oral autoantigens as co-therapies for neurolog$276,000
R01 · FY2015 · NS · contact PI
Improved diagnostic and monitoring assays for thyroid cancer$390,222
R44 · FY2014 · CA · contact PI
Platform for practical delivery of oral autoantigens as co-therapies for neurolog$276,000
R01 · FY2014 · NS · contact PI
Improved diagnostic and monitoring assays for thyroid cancer$391,627
R44 · FY2013 · CA · contact PI
A Novel Therapy for Staphylococcal Enterotoxin B Poisoning$431,663
R42 · FY2010 · AI · contact PI
Improved diagnostic and monitoring assays for thyroid cancer$216,221
R43 · FY2010 · CA · contact PI
A Novel Therapy for Staphylococcal Enterotoxin B Poisoning$445,716
R42 · FY2009 · AI · contact PI
Novel therapy for treating Multiple Sclerosis$239,720
R43 · FY2009 · NS · contact PI
Efficacy of soybean-based vaccines using a model antigen$252,687
R01 · FY2007 · AI · contact PI
A Novel Therapy for Staphyloccocal Enterotoxin B poisoning$200,970
R41 · FY2007 · AI · contact PI
Efficacy of soybean-based vaccines using a model antigen$264,176
R01 · FY2006 · AI · contact PI
Efficacy of soybean-based vaccines using a model antigen$289,297
R01 · FY2005 · AI